LMR Partners’s Sharecare, Inc. Warrant SHCRW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,309,218
| Closed | -$200K | – | 1636 |
|
|
2024
Q2 | $185K | Hold |
2,309,218
| – | – | ﹤0.01% | 860 |
|
|
2024
Q1 | $42K | Hold |
2,309,218
| – | – | ﹤0.01% | 996 |
|
|
2023
Q4 | $53.3K | Hold |
2,309,218
| – | – | ﹤0.01% | 793 |
|
|
2023
Q3 | $69.3K | Buy |
2,309,218
+416,032
| +22% | +$31.1K | ﹤0.01% | 705 |
|
|
2023
Q2 | $359K | Buy |
1,893,186
+464,075
| +32% | +$71.3K | ﹤0.01% | 530 |
|
|
2023
Q1 | $2.03M | Buy |
1,429,111
+628,945
| +79% | +$166K | 0.03% | 439 |
|
|
2022
Q4 | $1.28M | Buy |
800,166
+423,565
| +112% | +$86.1K | 0.02% | 635 |
|
|
2022
Q3 | $716K | Buy |
376,601
+133,301
| +55% | +$25.7K | 0.01% | 815 |
|
|
2022
Q2 | $384K | Hold |
243,300
| – | – | 0.01% | 974 |
|
|
2022
Q1 | $601K | Hold |
243,300
| – | – | 0.01% | 949 |
|
|
2021
Q4 | $1.09M | Buy |
243,300
+75,000
| +45% | +$101K | 0.01% | 666 |
|
|
2021
Q3 | $1.39M | Buy |
+168,300
| New | +$246K | 0.02% | 558 |
|
LMR Partners's SHCRW Position: Q3 2024 in Review
LMR Partners sold out of Sharecare, Inc. Warrant (SHCRW) in Q3 2024, closing a stake of 2,309,218 shares — an estimated $200K sold.
LMR Partners first reported a position in SHCRW in Q3 2021 and held it in 12 quarters. The position peaked at $2.03M in Q1 2023. 12 funds tracked by Wall St. Rank hold SHCRW as of Q3 2024.
- LMR Partners reported no remaining Sharecare, Inc. Warrant position as of Q3 2024 after selling out during the quarter.
- LMR Partners sold 2,309,218 Sharecare, Inc. Warrant shares in Q3 2024, an estimated $200K.
- LMR Partners first reported a position in Sharecare, Inc. Warrant in Q3 2021 and held it in 12 quarters.
- LMR Partners's Sharecare, Inc. Warrant position peaked at $2.03M in Q1 2023.
- 12 funds tracked by Wall St. Rank held Sharecare, Inc. Warrant as of Q3 2024.
Based on LMR Partners's 13F filing for Q3 2024, filed 7 Nov 2024.